glp 1 and GLP-1 Agonists - What is it? What is GLP-1? The Hormone

Preventive Services Task Force (USPSTF) recommends screening for osteoporosis in women aged 65 years and older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman with no additional risk factors

GLP-1s are not recommended during pregnancy or while trying to conceive, as theres not enough safety data

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: From randomised trials to clinical practice

Approximately 49,000 members, representing 3.6 percent of the total insured population, were actively using GLP-1 medications

In the study, there was a statistically significant 24% relative risk reduction in the combined endpoint of kidney disease worsening, kidney failure, and death due to cardiovascular disease compared to placebo after three years, when added to standard of care